These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 21632464

  • 1. Phenotypic reversion of invasive neurofibromin-deficient schwannoma by FTS: Ras inhibition reduces BMP4/Erk/Smad signaling.
    Barkan B, Kloog Y, Ehrlich M.
    Mol Cancer Ther; 2011 Aug; 10(8):1317-26. PubMed ID: 21632464
    [Abstract] [Full Text] [Related]

  • 2. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
    Barkan B, Starinsky S, Friedman E, Stein R, Kloog Y.
    Clin Cancer Res; 2006 Sep 15; 12(18):5533-42. PubMed ID: 17000690
    [Abstract] [Full Text] [Related]

  • 3. Ras inhibition boosts galectin-7 at the expense of galectin-1 to sensitize cells to apoptosis.
    Barkan B, Cox AD, Kloog Y.
    Oncotarget; 2013 Feb 15; 4(2):256-68. PubMed ID: 23530091
    [Abstract] [Full Text] [Related]

  • 4. RAS/MEK-independent gene expression reveals BMP2-related malignant phenotypes in the Nf1-deficient MPNST.
    Sun D, Haddad R, Kraniak JM, Horne SD, Tainsky MA.
    Mol Cancer Res; 2013 Jun 15; 11(6):616-27. PubMed ID: 23423222
    [Abstract] [Full Text] [Related]

  • 5. Ras inhibition by FTS attenuates brain tumor growth in mice by direct antitumor activity and enhanced reactivity of cytotoxic lymphocytes.
    Aizman E, Mor A, Levy A, George J, Kloog Y.
    Oncotarget; 2012 Feb 15; 3(2):144-57. PubMed ID: 22323550
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Neuroprotective Effect of S-trans, Trans-farnesylthiosalicylic Acid via Inhibition of RAS/ERK Pathway for the Treatment of Alzheimer's Disease.
    Wang X, Wang Y, Zhu Y, Yan L, Zhao L.
    Drug Des Devel Ther; 2019 Feb 15; 13():4053-4063. PubMed ID: 31819374
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combinatorial therapeutic targeting of BMP2 and MEK-ERK pathways in NF1-associated malignant peripheral nerve sheath tumors.
    Ahsan S, Ge Y, Tainsky MA.
    Oncotarget; 2016 Aug 30; 7(35):57171-57185. PubMed ID: 27494873
    [Abstract] [Full Text] [Related]

  • 14. Ras inhibition results in growth arrest and death of androgen-dependent and androgen-independent prostate cancer cells.
    Erlich S, Tal-Or P, Liebling R, Blum R, Karunagaran D, Kloog Y, Pinkas-Kramarski R.
    Biochem Pharmacol; 2006 Aug 14; 72(4):427-36. PubMed ID: 16780807
    [Abstract] [Full Text] [Related]

  • 15. Ras chaperones: new targets for cancer and immunotherapy.
    Kloog Y, Elad-Sfadia G, Haklai R, Mor A.
    Enzymes; 2013 Aug 14; 33 Pt A():267-89. PubMed ID: 25033809
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.